FDA approves immune checkpoint inhibitor drug for patients with resectable locally advanced head and neck cancer, backed by Dana-Farber research
Business Announcement
Updates every hour. Last Updated: 15-Jun-2025 08:09 ET (15-Jun-2025 12:09 GMT/UTC)